Company: BDRX
Filing Date: 2025-01-21
Form Type: 424B3
Source: 0001214659-25-000938
Chunk: 16

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-21
Form: 424B3
Chunk 16
---
 Price on the applicable VWAP Purchase Date for such VWAP Purchase.

| -6- |

(qq) “” means, with respect to a VWAP Purchase made pursuant to hereof, the lesser of ninety-five percent
(95%) of (i) the Closing Sale Price of Depositary Shares on the Business Day immediately preceding such applicable VWAP Purchase Date
(to be appropriately adjusted for any reorganization, recapitalization, non-cash dividend, share split, reverse share split, Depositary
Share-Ordinary Share ratio change or other similar transaction); and (ii) the VWAP for the period beginning at 9:30:01 a.m., Eastern time,
on the applicable VWAP Purchase Date, or such other time publicly announced by the Principal Market as the official open (or commencement)
of trading on the Principal Market on such applicable VWAP Purchase Date (the “”), and
ending at the earliest of (A) 11:00:00 a.m., Eastern time, on such applicable VWAP Purchase Date, (B) such time, from and after the VWAP
Purchase Commencement Time for such VWAP Purchase, that the total number (or volume) of Depositary Shares traded on the Principal Market
has exceeded the applicable VWAP Purchase Share Volume Maximum, and (C) such time, from and after the VWAP Purchase Commencement Time
for such VWAP Purchase, that the Sale Price has fallen below the applicable VWAP Purchase Minimum Price Threshold (such earliest time
described in (ii)(A), (ii)(B) and (ii)(C) above, the “”). Notwithstanding the foregoing,
in the event that (a) the Investor is the holder of any Depositary Shares on the VWAP Purchase Date that were the subject of a VWAP Purchase
Notice for such VWAP Purchase Date and (b) if within three (3) Business Days following a VWAP Purchase Date, the Company issues or sells
any Depositary Shares or Ordinary Share Equivalents (calculated on an as converted, as exercised basis), in each case other than pursuant
to an Exempt Issuance, pursuant to which Depositary Shares may be acquired at a New Issuance Price, then at the option of the Investor,
the VWAP Purchase Price related to that subject VWAP Purchase Notice may be reduced to the New Issuance Price, subject to
hereof.

(rr) “” means, with respect to a VWAP Purchase made pursuant to here